Product
R
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1 Clinical Study to Evaluate the Pharmacokinetic Comparability, Safety, Tolerability, and Immunogenicity of Felzartamab for Injection in Healthy Male Adult Subjects in China (Randomized, Double-blind, Crossover Design)Status: Recruiting, Estimated PCD: 2024-12-31